WALTHAM, Mass., May 13 Millennium Research Group's (MRG's)Urology/Gynecology Marketrack(TM) results indicate a potential for movement inglobal endometrial ablation (GEA) and benign prostatic hyperplasia (BPH)procedures from hospitals to ambulatory surgical centers (ASCs) and offices.Over 80% of urology and over 70% of gynecology procedures tracked in Q4 2007were performed in hospitals. MRG expects that these numbers will begin toshift to ASCs and office settings over time, providing additional marketpotential if manufacturers can implement effective marketing strategiestargeting these settings.
In November 2007, the Centers for Medicare & Medicaid Services (CMS)announced favorable reimbursement for various urology and gynecologyprocedures performed in ASCs and offices rather than in traditional hospitalsettings. In addition to the new ASC and office-based reimbursement structure,which took effect in 2008, there is a great deal of upside potential in thismarket given that doctors are capable of performing higher procedure volumesin-office, unlike in a hospital setting, where they have to compete foroperating room space. The physician office setting can also be morecomfortable than a hospital, making more patients willing to undergoprocedures in-office.
"The reimbursement shift may encourage physician and patient adoption ofin-office GEA or BPH procedures, expanding the number of facilities performingthem," says Nadia Lachowsky, Senior Marketrack(TM) Analyst at MillenniumResearch Group, "However, the successful transition of GEA and BPH to theoffice setting must be facilitated by various manufacturers in the market.Device manufacturers will need to provide extensive support to doctors whowish to adopt the procedure, including treatment advice, procedural training,advertising campaigns, and business/practice management support."
Millennium Research Group will be attending the American UrologicalAssociation (AUA) annual meeting in Orlando, Florida from May 17 to 20. Cometo booth #3031 for a preview of the Urology/Gynecology Marketrack(TM) data.
About Urology/Gynecology Marketrack(TM)
Urology/Gynecology Marketrack(TM) gathers data from over 300 hospitals,ASCs, and urology and gynecology offices throughout the US on a quarterlybasis. Product categories covered include female sterilization, GEA,endometrial resection, vaginal slings, pelvic floor reconstruction, BPH, andkidney stone management. Marketrack(TM) subscribers receive thousands of datapoints, including usage (units, average selling prices, and revenues),procedure, competitor, and brand-level information.
About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources, Inc.company (www.DecisionResources.com), is the global authority on medicaltechnology market intelligence and a leading provider of strategic informationto the health care sector. Focused solely on the medical device,pharmaceutical, and biotechnology industries, the company provides its clientswith the benefits of its specialized industry expertise through publishedreports and customized consulting services.
All company, brand, or product names contained in this document may betrademarks or registered trademarks of their respective holders.For more information, contact: Amy Krohn Millennium Research Group 416-364-7776 x101 [email protected]
SOURCE Millennium Research Group